or
a pharmaceutical composition according to
claim 12 of the Huang application,
or
a method according to claim 13 of the Huang
application,
or
a compound according to claim 24 of the
Prasit application,
or
a pharmaceutical composition according to
claims 15-16 of the Prasit application,
or
a method according to claims 17-18 of the
Prasit application.
11. The count can be summarized as being the first
compound set out below (the Huang claim 1 compound), or the
second compound set out below (the Prasit claim 24 compound),
a pharmaceutical composition containing either of the
compounds, or a method of treating inflammatory diseases or
cyclooxygenase mediated diseases with either of the compounds.
The Huang compound:
A compound of the formula:
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007